Abstract:Objective: To investigate the protective mechanism of zinc finger protein A20 over-expression in acute myocardial infarction (AMI) rats. Methods: Forty-five Sprague Dawley (SD) rats were randomly divided into sham group, model group and observation group. The model and observation groups were injected with normal saline and pcDNA3.1-A20 plasmid in the pre-operative 24 hour, respectively. The AMI model was established by ligating the left anterior descending coronary arteries of the model group and the observation group. The sham group were only treated with left anterior descending coronary artery threading but not ligation. The levels of A20 messenger ribonucleic acids (mRNA) and protein were detected by, reverse transcription polymerase chain reaction (RTPCR) and Western blot. The levels of tumour necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6) proteins in the peripheral blood were detected by the enzyme-linked immunosorbent assay (ELISA). The myocardial infarct size was analysed by triphenyl tetrazolium (TTC) staining. Results: Compared with the sham group, the levels of A20 mRNA and protein in the myocardium of the model and observation groups were significantly increased; the level in observation group was significantly higher than that of model group (p < 0.05). Compared with sham group, the level of nuclear factor-κB (NF-κB) p65 protein in the myocardium of the model and observation groups was activated into the nucleus, and NF-κB p65 protein in the nucleus in the observation group was significantly lower than that of the model group (p < 0.05). Compared with the sham group, the levels of TNF-α and IL-6 proteins in the peripheral blood in the model and observation groups were significantly increased (p < 0.05). The myocardial infarct size was significantly increased in the model and observation groups (p < 0.05), while the myocardial infarct size in the observation group was significantly decreased compared with the model group (p < 0.05). Conclusion: Zinc finger protein A20 can significantly inhibit the inflammatory injury and cell apoptosis process in AMI rats, which may be related to its inhibition of the expression and activation of nuclear transcription factor NF-κB.

Tumor Suppressor A20 Protects Against Cardiac Hypertrophy and Fibrosis by Blocking Transforming Growth Factor- -Activated Kinase 1-Dependent Signaling

Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling

Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction

A20 is dynamically regulated in the heart and inhibits the hypertrophic response

A20 Overexpression under Control of Mouse Osteocalcin Promoter in MC3T3-E1 Cells Inhibited Tumor Necrosis Factor-Alpha-induced Apoptosis.

Antiapoptotic Effect Both in Vivo and in Vitro of A20 Gene when Transfected into Rat Hippocampal Neurons

Neuroprotective Effect of A20 on TNF-Induced Postischemic Apoptosis

A20 prevents obesity-induced development of cardiac dysfunction

A20 attenuates vascular smooth muscle cell proliferation and migration through blocking PI3k/Akt singling in vitro and in vivo

Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation

A20 Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension by Inhibiting NF-κB Activation and Pulmonary Artery Smooth Muscle Cell Proliferation.

Protective Mechanism of A20 Protein Overexpression in Acute Myocardial Infarction Rats

Fibroblast growth factor 20 ameliorates cardiac hypertrophy via activation ErbB2

A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses

A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling

A20 Inhibits Human Salivary Adenoid Cystic Carcinoma Cells Invasion Via Blocking Nuclear Factor-Kappa B Activation

A20 controls expression of beta-cell regulatory genes and transcription factors

A20 Deficiency Leads to Angiogenesis of Pulmonary Artery Endothelial Cells Through Stronger NF‐κB Activation under Hypoxia

Artificial Zinc-Finger Transcription Factor of A20 Suppresses Restenosis in Sprague Dawley Rats after Carotid Injury via the PPARα Pathway.

Up-regulated A20 Promotes Proliferation, Regulates Cell Cycle Progression and Induces Chemotherapy Resistance of Acute Lymphoblastic Leukemia Cells.

Inhibition of A20 Expression in Tumor Microenvironment Exerts Anti-Tumor Effect Through Inducing Myeloid-Derived Suppressor Cells Apoptosis